FARKODAS 1 - Farmakoterapi Rasional
FARKODAS 1 - Farmakoterapi Rasional
FARKODAS 1 - Farmakoterapi Rasional
FARMAKOTERAPI RASIONAL
DISUSUN OLEH :
DEASY NUR CHAIRIN HANIFA, M.CLIN.PHARM., APT.
Tipe pembelajar
WHO AM I ???
????
Teacher Centred Learning Student Centred Learning
(TCL) (SCL)
vs
SUKSES
????
Penilaian
Skor akhir =
• 10 % kehadiran
• 15 % Tugas Mandiri (kuis) dan keaktifan
• 10 % Tugas Terstruktur
• 30 % UTS
• 35 % UAS
COURSE OUTLINE
PENDAHULUAN 1. FARMAKOTERAPI RASIONAL
SALURAN 2. PEPTIC ULCER DISEASE (PUD)
PENCERNAAN 3. GERD
PENGLIHATAN 4. GLAUCOMA, KONJUNCTIVITY, KATARAK,
RABUN, DLL
SALURAN 5. ASMA
PERNAPASAN 6. COPD
7. TBC
8. PNEUMONIA
ENDOKRIN + 9. OSTEOARTRITIS
RHEUMATOLOGI 10. RHEUMATOID ARTRITIS
11. GOAT
12. OSTEPOROSIS
13. DIABETES MELLITUS
14. THYROID
Mari kita mulai.....
• the study of pharmaca or biologi-
cally active chemical, on intact
animal organism.
• Not restricted to therapeutic agent or
Pharmacology drug, also applies to all active agent
such as fungicides, insecticides etc.
Nonpharmacology Surgery
Alternative therapy
Therapy
approach
• 1600 chemical agents
• 40.000 formulations
• 100.000 OTC
Pharmacology
Drug therapy
Pharmacotherapy Imunotherapy
Genetherapy
Process of rational drug therapy
6. Making alliance
with patient, 5. Choosing
following endpoints
endpoints to follow
Rational therapeutics
Obat yang diresepkan dengan cara yang
memaksimalkan efek klinis (memaksimalkan
efikasi dan meminimalkan toksisitas), status
fungsional, dan kepuasan pasien secara
keseluruhan, dengan biaya total yang harus
dikeluarkan serendah mungkin.
Waktu
terbatas
Prescribing
Individual
preference
Ketidak-
tahuan
Tekanan
industri farmasi
Problems in Irrational
Therapy
% drugs that are prescribed
unnecessarily
estimated by a comparison of expected versus actual prescription
80
70
60
50
40
30
20
10
0
Nepal Yemen Nigeria
Ghana
Cameroon
Nigeria
Sudan
Tanzania
Zimbabwe
ASIA
Yemen
Indonesia
Nepal
Eastern Caribean
and up to 160,000 infections of HIV per
year associated with injections
0% 10% 20% 30% 40% 50% 60%
% of primary care patients receiving injections
Source: Quick et al, 1997, Managing Drug Supply
30 to 60 % of PHC patients receive
antibiotics - perhaps twice what is
clinically needed
AFRICA
Sudan
Sw aziland
Cam eroon
Ghana
Tanzania
Zim babw e
ASIA
Indonesia
Nepal
Bangladesh
L.AMER. & CAR.
Eastern Caribean
El Salvador
Jam aica
Guatem ala
• Malaria
– choroquine resistance in 81/92 countries
• Tuberculosis
– 2 - 40 % primary multi-drug resistance
• Gonorrhoea
– 5 - 98 % penicillin resistance in N. gonorrhoeae
• Pneumonia and bacterial meningitis
– 12 - 55 % penicillin resistance in S. pneumoniae
• Diarrhoea: shigellosis
– 10-90+ % amp, 5-95% TMP/SMZ resistance
Source: DAP, EMC, GTB, CHD (1997)
WHO, Dept. Essential Drugs and Medicines Policy
Konsekuensi Ekonomi
Contoh:
- penggunaan produk bermerek mahal, sementara obat generik
yang lebih murah tersedia,
- Peresepan kombinasi,
- resep multi-obat
Improve Rational Therapy
1. Educational
Prescribers
2. Managerial
Intervention
Type
3. Financial Consumers
4. Regulatory